Sharekhan

Anuh Pharma Ltd

Fri 29/08/2025,15:54:10 NSE: ANUHPHR

₹ 87.36 0.42 (0.48%)
BUY NOW Buy Anuh Pharma Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock Anuh Pharma Ltd

Fri 29/08/2025,16:1:0

Anuh Pharma Ltd

Fri 29/08/2025,15:54:10 | NSE : ANUHPHR

₹ 87.360.42 (0.48%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 86.94

Previous Close

₹ 86.94

Volume

15350

Mkt Cap ( Rs. Cr)

₹875.56

High

₹ 88.74

Low

₹ 86.53

52 Week High

₹ 122.85

52 Week Low

₹ 74.25

Book Value Per Share

₹ 32.53

Dividend Yield

1.71

Face Value

₹ 5.00

What’s Your Call?

Collective community sentiment on Anuh Pharma Ltd

Your Vote -

Buy

85.00%

Hold

10.00%

Sell

5.00%

85.00%

20 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

100%

Sell Order Quantity

0%

Bid Price

Qty

87.36

80

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

80

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Anuh Pharma Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Anuh Pharma Ltd - Announcement under Regulation 30 (LODR)-Change in Management

    26 Aug 2025, 8:06PM Disclosure under Regulation 30 of SEBI (LODR), 2015 regarding Change in Management.

  • Anuh Pharma Ltd - Announcement Under Regulation 30 - General Updates

    26 Aug 2025, 8:04PM Disclosure of Announcement under Regulation 30 of SEBI (LODR), 2015

  • Anuh Pharma Ltd - Change in Management

    26 Aug 2025, 8:00PM Anuh Pharma Limited has informed the Exchange about change in Management

  • Anuh Pharma Ltd - General Updates

    26 Aug 2025, 7:52PM Anuh Pharma Limited has informed the Exchange about General Updates under Regulation 30

  • Anuh Pharma Ltd - Shareholders meeting

    26 Aug 2025, 7:30PM Anuh Pharma Limited has submitted the Exchange a copy Voting Results and Scrutinizers report of Annual General Meeting held on August 22, 2025

  • Anuh Pharma Ltd - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    26 Aug 2025, 7:18PM Submission of Scrutinizer Report and Voting Results for the 65th Annual General Meeting of the Company.

  • Anuh Pharma Ltd - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    26 Aug 2025, 7:18PM Submission of Scrutinizer Report and Voting Results for the 65th Annual General Meeting of the Company.

  • Anuh Pharma Ltd - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    26 Aug 2025, 7:18PM Submission of Scrutinizer Report and Voting Results for the 65th Annual General Meeting of the Company.

  • Anuh Pharma Ltd - Shareholder Meeting / Postal Ballot-Outcome of AGM

    22 Aug 2025, 6:40PM Outcome of the 65th Annual General Meeting of Anuh Pharma Limited held on Friday, 22nd August, 2025.

  • Anuh Pharma Ltd - Shareholders meeting

    22 Aug 2025, 6:36PM Anuh Pharma Limited has informed the Exchange regarding Proceedings of 65th Annual General Meeting held on August 22, 2025

  • Anuh Pharma Ltd - Investor Presentation

    22 Aug 2025, 1:41PM Anuh Pharma Limited has informed the Exchange about Investor Presentation

  • Anuh Pharma Ltd - Announcement under Regulation 30 (LODR)-Investor Presentation

    22 Aug 2025, 1:35PM Investor Presentation for Q1 FY 2025-26

  • Anuh Pharma Ltd - General Updates

    20 Aug 2025, 6:26PM Anuh Pharma Limited has informed the Exchange regarding 100 Days Campaign -Saksham Niveshak

  • Anuh Pharma Ltd - Intimation Regarding 100 Days Campaign - 'Saksham Niveshak'

    20 Aug 2025, 6:15PM Intimation Regarding 100 Days Campaign - 'Saksham Niveshak'

  • Anuh Pharma Ltd - Intimation Regarding 100 Days Campaign - 'Saksham Niveshak'

    20 Aug 2025, 6:15PM Intimation Regarding 100 Days Campaign - 'Saksham Niveshak'

  • Anuh Pharma Ltd - Intimation Regarding 100 Days Campaign - 'Saksham Niveshak'

    20 Aug 2025, 6:15PM Intimation Regarding 100 Days Campaign - 'Saksham Niveshak'

  • Anuh Pharma Ltd - Intimation Regarding 100 Days Campaign - 'Saksham Niveshak'

    20 Aug 2025, 6:15PM Intimation Regarding 100 Days Campaign - 'Saksham Niveshak'

  • Anuh Pharma Ltd - Copy of Newspaper Publication

    9 Aug 2025, 5:38PM Anuh Pharma Limited has informed the Exchange about Copy of Newspaper Publication of the Un-Audited financial results for the Quarter ended 30th June,

  • Anuh Pharma Ltd Q1 net profit down 12.72% at Rs 8.30 cr

    8 Aug 2025, 6:20PM The company reported standalone net profit of Rs 8.30 crore for the quarter ended June 30, 2025 as compared to Rs 9.51 crore in the same period last y

  • Anuh Pharma Ltd - Appointment

    8 Aug 2025, 6:20PM Anuh Pharma Limited has informed the Exchange regarding Appointment of Mr. Vinayak Shenoy as Chief Marketing Officer of the company w.e.f. August 11,

  • Anuh Pharma Ltd - Announcement under Regulation 30 (LODR)-Change in Management

    8 Aug 2025, 6:18PM Appointment of Chief Marketing Officer

  • Anuh Pharma Ltd - Results-Financial Results For June 30, 2025

    8 Aug 2025, 6:13PM Unaudited Financial Results for the Quarter ended 30th June, 2025

  • Anuh Pharma Ltd - General Updates

    8 Aug 2025, 6:13PM Anuh Pharma Limited has informed the Exchange about appointment of Chief Marketing Officer of the Company

  • Anuh Pharma Ltd - Outcome of Board Meeting

    8 Aug 2025, 5:40PM Anuh Pharma Limited has informed the Exchange regarding the approval of Un-audited Financial Results and appointment of Chief Marketing Officer during

  • Anuh Pharma Ltd - Outcome of Board Meeting

    8 Aug 2025, 5:37PM Anuh Pharma Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.

  • Anuh Pharma Ltd - Board Meeting Outcome for Outcome For The Board Meeting Held On 08/08/2025

    8 Aug 2025, 5:14PM To consider and approve the Un-audited Financial results along with Limited Review Report for the quarter ended 30th June, 2025 and appointment of Chi

  • Anuh Pharma Ltd - Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter Ende

    1 Aug 2025, 4:05PM Anuh Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2025 ,inter alia, to consider and appr

  • Anuh Pharma Ltd - Corrigendum

    30 Jul 2025, 4:51PM Anuh Pharma Limited has informed the Exchange regarding Corrigendum for the Notice of 65th Annual General Meeting, Book Closure & E-voting Information

  • Anuh Pharma Ltd - Shareholder Meeting - Rectified Covering Letter For Notice Of Annual General Meeting On Friday, 22Nd August

    29 Jul 2025, 6:20PM In continuation with the earlier intimation being made on Exchange on 29/07/2025, please find attached the rectified covering letter along with Notice

  • Anuh Pharma Ltd - Revised Record date

    29 Jul 2025, 2:21PM Anuh Pharma Limited had intimated the 14-Aug-2025 as the record date. The Company has now informed the Exchange that the Record date has been revised

  • Anuh Pharma Ltd - Updates

    29 Jul 2025, 2:08PM Anuh Pharma Limited has informed the Exchange regarding dispatch of physical communication to shareholders who have not registered their email address

  • Anuh Pharma Ltd - Copy of Newspaper Publication

    29 Jul 2025, 1:44PM Anuh Pharma Limited has informed the Exchange about Copy of Newspaper Publication

  • Anuh Pharma Ltd - Shareholders meeting

    29 Jul 2025, 1:15PM Anuh Pharma Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 22, 2025

  • Anuh Pharma Ltd - Corporate Action - Fixes Revised Record Date For Dividend And Annual General Meeting

    29 Jul 2025, 2:26PM The Revised Record for the Dividend and Annual General Meeting is fixed and the same is enclosed herewith.

  • Anuh Pharma Ltd - General Updates

    29 Jul 2025, 2:14PM This is to inform to the stock exchange regarding dispatch of physical communication to shareholders who have not registered their email address.

  • Anuh Pharma Ltd - Reg. 34 (1) Annual Report.

    29 Jul 2025, 1:30PM Pursuant to the provisions of Regulation 34(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulat

  • Anuh Pharma Ltd - Shareholder Meeting - Annual General Meeting On Friday, 22Nd August, 2025

    29 Jul 2025, 1:01PM In terms of the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please f

  • Anuh Pharma Ltd - Spurt in Volume

    22 Jul 2025, 10:39AM Significant increase in volume has been observed in Anuh Pharma Limited. The Exchange, in order to ensure that investors have latest relevant informat

  • Anuh Pharma Ltd - Clarification Sought From Anuh Pharma Ltd

    22 Jul 2025, 1:37PM Please find attached the clarification on Spurt in volume.

  • Anuh Pharma Ltd - Clarification sought from Anuh Pharma Ltd

    22 Jul 2025, 12:56PM The Exchange has sought clarification from Anuh Pharma Ltd on July 22, 2025, with reference to Movement in Volume.<BR><BR>The reply is awaited.

  • Anuh Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended July 16, 2025

    22 Jul 2025, 11:11AM As of July 2025, 69.92% is owned by Promoters and 30.08% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 69.90% and Forei

  • Anuh Pharma Ltd has declared 30% Final dividend for the financial year March 2025

    19 Jul 2025, 7:05AM Anuh Pharma Ltd. on Friday, 23 May 2025, has announced Final dividend of 30 percent on Equity Share, to its shareholders holding shares on the registe

  • Anuh Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2025

    19 Jul 2025, 7:00AM As of June 2025, 69.92% is owned by Promoters and 30.08% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 69.90% and Forei

  • Anuh Pharma Ltd - Alteration Of Capital and Fund Raising-XBRL

    16 Jul 2025, 11:29AM ANUH PHARMA LIMITED has informed the Exchange regarding Allotment of Securities

  • Anuh Pharma Ltd - Allotment of Securities

    16 Jul 2025, 11:27AM Anuh Pharma Limited has informed the Exchange regarding allotment of securities pursuant to Bonus at its meeting held on 0 ,

  • Anuh Pharma Ltd - Announcement under Regulation 30 (LODR)-Allotment

    16 Jul 2025, 11:23AM Disclosure regarding allotment of 50112000 equity shares pursuant to Bonus issue.

  • Anuh Pharma Ltd - General Updates

    15 Jul 2025, 2:59PM Anuh Pharma Limited has informed the Exchange about Inauguration of Manufacturing Block INT 1A of the Company

  • Anuh Pharma Ltd - Announcement Under Regulation 30 (LODR) - Inauguration Of Manufacturing Block INT 1A Of The Company.

    15 Jul 2025, 2:50PM This is to inform that the company has inaugurated it's new manufacturing Block INT 1A at E-17/3, E-17/4 & E-18, M.I.D.C., Tarapur, Boisar, Dist Palgh

  • Anuh Pharma Ltd - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    8 Jul 2025, 5:13PM Anuh Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

  • Anuh Pharma Ltd - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    8 Jul 2025, 5:29PM Enclosed herewith is the Voting Results and Scrutinizer Report for Postal Ballot Notice dated 23rd May, 2025.

  • Anuh Pharma Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    8 Jul 2025, 5:08PM Compliance Certificate pursuant to Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th June, 2025 r

  • Anuh Pharma Ltd - Record Date

    7 Jul 2025, 5:54PM Anuh Pharma Limited has informed the Exchange that Record date for the purpose of Bonus is 15-Jul-2025.

  • Anuh Pharma Ltd - Corporate Action - Record Date For Issue Of Bonus Equity Shares Of The Company.

    7 Jul 2025, 5:48PM The Company has fixed Tuesday, 15th July, 2025, as the \Record Date\ for the purpose of issuance of Bonus Shares of the Company.

  • Anuh Pharma Ltd - Shareholders meeting

    7 Jul 2025, 3:29PM Anuh Pharma Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot

  • Anuh Pharma Ltd - Disclosure under SEBI Takeover Regulations

    3 Jul 2025, 11:02PM Anuh Pharma Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substanti

  • Anuh Pharma Ltd - Trading Window-XBRL

    26 Jun 2025, 4:43PM ANUH PHARMA LIMITED has informed the Exchange about Closure of Trading Window

  • Anuh Pharma Ltd - Trading Window

    26 Jun 2025, 4:38PM Anuh Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

  • Anuh Pharma Ltd - Copy of Newspaper Publication

    7 Jun 2025, 3:49PM Anuh Pharma Limited has informed the Exchange about Copy of Newspaper Publication

  • Anuh Pharma gets nod from WHO

    29 Sep 2020 , 10:28AM Anuh Pharma Ltd receives approval from WHO for Pyrimcthamine API
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Anuh Pharma Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 336.5229 293.2313 241.2214 216.8838 204.2412
Liabilities 336.5229 293.2313 241.2214 216.8838 204.2412
Equity 25.056 25.056 25.056 25.056 25.056
Gross Profit 60.9087 75.1491 51.2745 46.8455 44.5835
Net Profit 47.3519 60.0575 36.1796 30.5613 28.4363
Cash From Operating Activities 37.1248 12.9251 53.9016 28.8637 -18.7347
NPM(%) 7.15 9.28 6.85 6.27 6.58
Revenue 661.5149 647.0043 527.486 486.6462 431.9601
Expenses 600.6062 571.8552 476.2115 439.8007 387.3766
ROE(%) 14.52 18.42 11.09 9.37 8.72

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
14 Aug 2025 1.5 30 1.72 207.39

Peers

Other companies within the same industry or sector that are comparable to Anuh Pharma Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 801.40 0.71 72.66 49.92 301.39 0.62
Lotus Eye Hospital and Institute Ltd 116.84 6.98 376.90 181.88 3.55 0.00
Vaishali Pharma Ltd 12.24 -0.81 408.00 93.75 3.13 0.00
Astec Lifesciences Ltd 872.70 1.80 0.00 171.52 -604.77 0.00

Company Info

1961 - Anuh Pharma Ltd was incorporated. 2006 - In early January, the promoters sold off nearly 14.9% of their stake in the company. -Anuh Pharma has given the Bonus in the Ratio of 1:1 -Company has splits its Face value of Shares from Rs 10 to Rs 5 2010 -Anuh Pharma has given the Bonus in the Ratio of 2:1 2011 -Anuh Pharma has recommended a Dividend of Rs. 5.00 per share of face value of Rs. 5.00. 2012 -Anuh Pharma Ltd has entered into a Memorandum of Understanding with M/s. Invent Pharma Pvt. Ltd., to acquire all fixed assets of their Research & Development Laboratory. -Anuh Pharma has recommended a dividend of Rs. 5.50 per equity share of face value of Rs. 5.00. 2013 -Anuh Pharma has recommended a dividend of Rs. 6.00 per equity share of face value of Rs. 5.00. 2014 -Anuh Pharma Ltd have received approval from COFEPRIS (Health Authority of Mexico) GMP certificate for three of Companys Erythromycin products namely Erythromycin Estolate, Erythromycin Ethyl Succinate & Erythromycin Stearate. -Anuh Pharma has recommended a Final Dividend of Rs. 6.50 (130%) per share. 2015 -The Company has allotted the Bonus Shares to its shareholders in the Ratio of 2:1. 2016 -Anu Pharma Ltd has received EUGMP Certificate granted by ANSM - France. 2020 -The Company has issued Bonus Shares in the Ratio of 1:1.

1961 - Anuh Pharma Ltd was incorporated. 2006 - In early January, the promoters sold off nearly 14.9% of their stake in the company. -Anuh Pharma has given the Bonus in the Ratio of 1:1 -Company has splits its Face value of Shares from Rs 10 to Rs 5 2010 -Anuh Pharma has given the Bonus in the Ratio of 2:1 2011 -Anuh Pharma has recommended a Dividend of Rs. 5.00 per share of face value of Rs. 5.00. 2012 -Anuh Pharma Ltd has entered into a Memorandum of Understanding with M/s. Invent Pharma Pvt. Ltd., to acquire all fixed assets of their Research & Development Laboratory. -Anuh Pharma has recommended a dividend of Rs. 5.50 per equity share of face value of Rs. 5.00. 2013 -Anuh Pharma has recommended a dividend of Rs. 6.00 per equity share of face value of Rs. 5.00. 2014 -Anuh Pharma Ltd have received approval from COFEPRIS (Health Authority of Mexico) GMP certificate for three of Companys Erythromycin products namely Erythromycin Estolate, Erythromycin Ethyl Succinate & Erythromycin Stearate. -Anuh Pharma has recommended a Final Dividend of Rs. 6.50 (130%) per share. 2015 -The Company has allotted the Bonus Shares to its shareholders in the Ratio of 2:1. 2016 -Anu Pharma Ltd has received EUGMP Certificate granted by ANSM - France. 2020 -The Company has issued Bonus Shares in the Ratio of 1:1.

Read More

Parent Organisation

Anuh Pharma Ltd.

Founded

19/02/1960

Managing Director

Mr.Ritesh B Shah

NSE Symbol

ANUHPHREQ

FAQ

The current price of Anuh Pharma Ltd is ₹ 87.36.

The 52-week high for Anuh Pharma Ltd is ₹ 88.74 and the 52-week low is ₹ 86.53.

The market capitalization of Anuh Pharma Ltd is currently ₹ 875.56. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Anuh Pharma Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Anuh Pharma Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Anuh Pharma Ltd shares.

The CEO of Anuh Pharma Ltd is Mr.Ritesh B Shah, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT